KRAS

KRAS

KRAS 분자 정보

Molecule Name
GTPase KRas
분자 별명
GTPase Kras,K-Ras 2,Ki-Ras,c-K-ras,c-Ki-ras,KRAS2,RASK2,C-K-RAS,CFC2,K-RAS2A,K-RAS2B,K-RAS4A,K-RAS4B,KI-RAS,KRAS1,KRAS2,NS,NS3,RASK2,KRAS
Drug Development Progress
임상 약물 수40
시판 약물 수0
최고 연구 개발 단계Phase 2 Clinical
표적 별명
V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog,KRAS Proto-Oncogene, GTPase,K-Ras4B,KRAS1,KRAS2,V-Ki-Ras2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog,Kirsten Rat Sarcoma Viral Oncogene Homolog,GTPase KRas,C-Ki-Ras,K-Ras 2,RASK2,Kirsten Rat Sarcoma Viral Proto-Oncogene,Cellular Transforming Proto-Oncogene,Cellular C-Ki-Ras2 Proto-Oncogene,Kras-Enoph1 Fusion Protein,Transforming Protein P21,PR310 C-K-Ras Oncogene,C-Kirsten-Ras Protein,Proto-Oncogene GTPase,K-Ras P21 Protein,KRAS-ENOPH Fusion,Oncogene KRAS2,EC 3.6.5.2,C-Ki-Ras2,'C-K-RAS,C-K-RAS,K-RAS2A,K-RAS2B,K-RAS4A,C-K-Ras,KI-RAS,Ki-Ras,K-Ras,CFC2,RALD,NS3,OES,NS
분자 배경
KRAS (Kirsten rat sarcoma 2 viral oncogene homolog) gene is a proto-oncogene that encodes a small GTPase transductor protein called KRAS. KRAS is also known as Ki-Ras, c-K-ras and c-Ki-ras. Ras proteins bind GDP/GTP and possess intrinsic GTPase activity. Plays an important role in the regulation of cell proliferation, promoting oncogenic events by inducing transcriptional silencing of tumor suppressor genes (TSGs) in colorectal cancer (CRC) cells in a ZNF304-dependent manner. RAS is one of the most frequently mutated oncogenes in human cancer but the frequency and distribution of RAS gene mutations are not uniform. In details, mutation of glycine 12 (G12) causes RAS activation by interfering with GAP binding and GAP-stimulated GTP hydrolysis. The reference shows the pathway may as a potential therapy targets.

KRAS 제품 목록

Species
  • Human(14)
Tag
  • His Tag(11)
  • His Tag & Avi Tag(3)
Host
  • E. coli(13)
  • InsectCells(1)
Conjugate
  • Unconjugated(14)
Grade
  • RUO(14)
Low Endotoxin
  • No(14)
분자Cat. No.Product Name종Host구조순도Activity규격 및 가격
KRAS
Human KRAS (2-185, G12D) Protein, His Tag
Human
E. coli
HPLCSDS-PAGE
SPR

$1180.00

250ug
KRAS
Human KRAS (G12V) Protein, His Tag (active enzyme)
Human
E. coli
SDS-PAGE
Enzyme

$245.00

50ug
KRAS
Human KRAS Protein, His Tag (active enzyme, HPLC verified)
Human
E. coli
HPLCSDS-PAGE
Enzyme

$410.00

100ug
KRAS
Human KRAS (2-185, G12C) Protein, His Tag (HPLC verified) (active enzyme)
Human
E. coli
HPLCSDS-PAGE
Enzyme

$140.00

50ug
KRAS
Human KRAS (2-185, G12D) Protein, His Tag (active enzyme)
Human
E. coli
SDS-PAGE
Enzyme

$245.00

50ug
KRAS
Human KRAS (G12S) Protein, His Tag (HPLC verified) (active enzyme)
Human
E. coli
HPLCSDS-PAGE
Enzyme

$245.00

50ug
KRAS
Human KRAS (G12A) Protein, His Tag (active enzyme)
Human
E. coli
SDS-PAGE
Enzyme

$140.00

50ug
KRAS
Human KRAS (G12R) Protein, His Tag (active enzyme)
Human
E. coli
SDS-PAGE
Enzyme

$140.00

50ug
KRAS
Human KRAS (Q61H) Protein, His Tag (active enzyme)
Human
E. coli
SDS-PAGE
Enzyme

$245.00

50ug
KRAS
Human KRAS (G13D) Protein, His Tag (active enzyme)
Human
E. coli
SDS-PAGE
Enzyme

$245.00

50ug
You Have Viewed 1-10 Of 14 Results
  • 1
  • 2

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
Pooled mutant-KRAS peptide vaccine (Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)Phase 2 ClinicalSidney Kimmel Comprehensive Cancer Center
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Pancreatic Neoplasms
상세
KRAS Neoantigen Nanovaccine (The Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School)Phase 2 ClinicalThe Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School
Colorectal Neoplasms; Pancreatic Neoplasms
상세
HBW-012462HBW-012462Phase 2 ClinicalHyperway Pharmaceutical Co Ltd
Solid tumours
상세
JAB-23E73JAB-23E73Phase 2 ClinicalJacobio Pharmaceuticals Group Co Ltd
Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Pancreatic Neoplasms; Solid tumours
상세
ZG-2001ZG2001; ZG-2001Phase 2 ClinicalSuzhou Zelgen Biopharmaceuticals Co Ltd
Neoplasms; Solid tumours
상세
ELI-002ELI-002 2P; Amph-CpG-7909; ELI-002; VED-002Phase 2 ClinicalElicio Therapeutics
Bile Duct Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Colorectal Neoplasms; Gallbladder Neoplasms; Neoplasm, Residual; Ovarian Neoplasms; Solid tumours
상세
mDC3/8-KRAS Vaccine (University of Pennsylvania)Phase 1 ClinicalUniversity Of Pennsylvania
Carcinoma, Pancreatic Ductal
상세
small molecule Ras inhibitors (Boehringer Ingelheim/Vanderbilt University)Phase 1 ClinicalBoehringer Ingelheim International Gmbh
Neoplasms
상세
KRAS peptide vaccine (Sidney Kimmel Cancer Center/Bristol-Myers Squibb)Phase 1 ClinicalSidney Kimmel Comprehensive Cancer Center
Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Pancreatic Neoplasms
상세
KrasG12D siRNA-loaded mesenchymal stromal cells-derived exosomes (Codiak BioSciences)Phase 1 ClinicalThe University Of Texas MD Anderson Cancer Center
Carcinoma, Pancreatic Ductal; Pancreatic Neoplasms
상세
HB-700HB700; HB-700Phase 1 ClinicalHookipa Pharma Inc
Colorectal Neoplasms; Lung Neoplasms; Neoplasms; Pancreatic Neoplasms
상세
KST-6051KST-6051Phase 1 ClinicalKestrel Therapeutics Inc
Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Solid tumours
상세
TQB-3205TQB-3205; TQB3205Phase 1 ClinicalJiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
Neoplasms
상세
PT-0511PT-0511; PT0511Phase 1 ClinicalPAQ Therapeutics Inc
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Pancreatic Neoplasms; Solid tumours
상세
TLN-372TLN-372Phase 1 ClinicalTreeline Biosciences Inc
Solid tumours
상세
ASP-5834ASP5834; ASP-5834Phase 1 ClinicalAstellas Pharma Inc
Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Solid tumours
상세
AMG-410AMG-410; AMG 410Phase 1 ClinicalAmgen Inc
Colorectal Neoplasms; Lung Neoplasms; Neoplasm Metastasis; Pancreatic Neoplasms; Solid tumours
상세
MPD-1MPD-1Phase 1 ClinicalPharosgen Co Ltd
Neoplasms; Solid tumours
상세
KRAS protein modulator (Eli Lilly and Company)Phase 1 ClinicalEli Lilly And Company
Neoplasms
상세
PF-07985045PF-07985045; PF-5045Phase 1 ClinicalPfizer Inc
Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Solid tumours
상세
LY-4066434LY-4066434Phase 1 ClinicalLoxo Oncology Inc
Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Solid tumours
상세
BGB-53038BGB-53038Phase 1 ClinicalBeOne Medicines Ltd
Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Esophageal adenocarcinoma; Esophageal Neoplasms; Gastrointestinal Neoplasms; Lung Neoplasms; Neoplasm Metastasis; Solid tumours; Stomach Neoplasms
상세
KRAS Neoantigen mRNA Vaccine(Abogen Biosciences)ABO2102; ABO-2102Phase 1 ClinicalAbogen Biosciences Co Ltd
Carcinoma, Non-Small-Cell Lung; Pancreatic Neoplasms; Solid tumours
상세
PF-07934040PF-4040; PF-07934040Phase 1 ClinicalPfizer Inc
Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Solid tumours
상세
ERAS-4001ERAS-4001Phase 1 ClinicalErasca Inc
Solid tumours
상세
BBO-11818BBO-11818Phase 1 ClinicalBridgebio Pharma Inc
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Neoplasms; Pancreatic Neoplasms
상세
ALTA-3263ALTA-3263Phase 1 ClinicalAlterome Therapeutics Inc
Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Neoplasms; Pancreatic Neoplasms; Solid tumours
상세
QTX-3544QTX-3544; QTX3544Phase 1 ClinicalQuanta Therapeutics Inc
Neoplasms; Solid tumours
상세
AN-9025AN-9025; AN9025Phase 1 ClinicalHangzhou Adlai Nortye Biopharma Co Ltd
Adenocarcinoma of Lung; Colorectal Neoplasms; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Solid tumours
상세
BI-3706674BI-3706674; BI3706674; BI 3706674Phase 1 ClinicalC.H. Boehringer Sohn Ag & Co. Kg
Esophageal Neoplasms; Solid tumours; Stomach Neoplasms
상세
YL-17231YL-17231; YL17231; TEB-17231Phase 1 ClinicalYL-Pharma
Neoplasms; Solid tumours
상세
QTX-3034QTX3034; QTX-3034Phase 1 ClinicalQuanta Therapeutics Inc
Neoplasms; Solid tumours
상세
ZoldonrasibRMC-9805; RM-036Phase 1 ClinicalRevolution Medicines Inc
Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Neoplasms; Solid tumours
상세
BEBT-607C200825009-FP; BEBT-607Phase 1 ClinicalGuangzhou BeBetter Medicine Technology Co
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Solid tumours
상세
BI-1701963BI-1701963Phase 1 ClinicalForma Therapeutics Holdings Inc
Colorectal Neoplasms; Solid tumours
상세
Targeted KRAS TCR-T cell therapy(Immuxell Biotech)ClinicalShanghai Immuxell Biotech Ltd
Carcinoma, Pancreatic Ductal
상세
CWG-59rCWG-59r; CWG-59-r; CWG59rClinicalCellworks Group
Neoplasms
상세
CWG-71bCWG-71b; CWG-71-b; CWG71bClinicalCellworks Group
Neoplasms
상세
CWG-89CWG-89ClinicalCellworks Group
Neoplasms
상세
CWG-71a (Cellworks Group)CWG-71aClinicalCellworks Group Inc
Neoplasms
상세
Customer Reviews